Gene Discoveries Give Hope Against "Brittle Bone" Disease, The New England Journal of Medicine Study
5/9/2013 7:27:13 AM
More...
|
Fish Oil Doesn't Help Prevent Heart Attacks, The New England Journal of Medicine Study Shows
5/9/2013 7:24:29 AM
More...
|
Ingredient in New MS Drug Linked to Serious Brain Disease, The New England Journal of Medicine Reveals
4/26/2013 7:24:11 AM
More...
|
Data From Phase 3 Studies of Gilead Sciences, Inc. (GILD)'S Sofosbuvir for Hepatitis C to be Presented at 48th Annual EASL Meeting; Findings Published Online Today in The New England Journal of Medicine
4/24/2013 9:33:39 AM
More...
|
Karmanos Cancer Institute Genitourinary Team Leader Contributes to Article on Prostate Cancer in The New England Journal of Medicine
4/8/2013 10:18:14 AM
More...
|
Research Published in The New England Journal of Medicine Demonstrates Marked and Long-Lasting Antiviral Activity Against HCV for Santaris Pharma A/S' Miravirsen, the First MicroRNA-Targeted Drug to Enter Clinical Trials
3/28/2013 8:51:39 AM
More...
|
FDA Perspective Published in The New England Journal of Medicine Reinforces Safety of Boehringer Ingelheim Corporation's Pradaxa® (dabigatran etexilate)
3/26/2013 11:08:41 AM
More...
|
FDA Perspective Published in The New England Journal of Medicine Reinforces Safety of Pradaxa® (dabigatran etexilate mesylate)
3/19/2013 9:42:24 AM
More...
|
Torax Medical Release: The New England Journal of Medicine Publishes Clinical Study of Minimally-Invasive Device for Treatment of Reflux Disease
2/21/2013 9:58:59 AM
More...
|
Boehringer Ingelheim Pharmaceuticals, Inc. Release: New Study Results Published in The New England Journal of Medicine Show Dabigatran Etexilate Mesylate Reduces the Risk of Recurrent Venous Thromboembolism
2/21/2013 9:30:17 AM
More...
|
|